{"id":"https://openalex.org/W3096790401","doi":"https://doi.org/10.1080/2162402x.2020.1832348","title":"Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions","display_name":"Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3096790401","doi":"https://doi.org/10.1080/2162402x.2020.1832348","mag":"3096790401","pmid":"https://pubmed.ncbi.nlm.nih.gov/33178494","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7595592"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2020.1832348","doi":"https://doi.org/10.1080/2162402x.2020.1832348","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2020.1832348","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1832348?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3096790401"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1832348?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058543770","display_name":"Lorena Incorvaia","orcid":"https://orcid.org/0000-0002-1199-7286","observed_orcids":["https://orcid.org/0000-0002-1199-7286"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorena Incorvaia","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.n.d.), Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":"https://orcid.org/0000-0002-1199-7286","affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.n.d.), Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056636166","display_name":"Daniele Fanale","orcid":"https://orcid.org/0000-0001-7668-737X","observed_orcids":["https://orcid.org/0000-0001-7668-737X"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Fanale","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7668-737X","affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056329331","display_name":"Giuseppe Badalamenti","orcid":"https://orcid.org/0000-0002-2478-8838","observed_orcids":["https://orcid.org/0000-0002-2478-8838"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Badalamenti","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018910230","display_name":"Camillo Porta","orcid":"https://orcid.org/0000-0003-2412-1563","observed_orcids":["https://orcid.org/0000-0003-2412-1563"]},"institutions":[{"id":"https://openalex.org/I4210095088","display_name":"Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari","ror":"https://ror.org/00pap0267","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210095088","https://openalex.org/I4210099368","https://openalex.org/I4210117053"]},{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Camillo Porta","raw_affiliation_strings":["University of Bari \u2018A.moro\u2019 and Division of Oncology, Policlinico Consorziale, Bari, Italy","Department of Biomedical Sciences and Human Oncology, University of Bari 'A.moro' and Division of Oncology, Policlinico Consorziale, Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0003-2412-1563","affiliations":[{"raw_affiliation_string":"University of Bari \u2018A.moro\u2019 and Division of Oncology, Policlinico Consorziale, Bari, Italy","institution_ids":["https://openalex.org/I4210095088","https://openalex.org/I5561750"]},{"raw_affiliation_string":"Department of Biomedical Sciences and Human Oncology, University of Bari 'A.moro' and Division of Oncology, Policlinico Consorziale, Bari, Italy","institution_ids":["https://openalex.org/I4210095088","https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029679351","display_name":"Daniel Olive","orcid":"https://orcid.org/0000-0003-1299-4113","observed_orcids":["https://orcid.org/0000-0003-1299-4113"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210144608","display_name":"Centre de Recherche en Canc\u00e9rologie de Marseille","ror":"https://ror.org/0494jpz02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210096427","https://openalex.org/I4210144608","https://openalex.org/I4210150365"]},{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Daniel Olive","raw_affiliation_strings":["Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Marseille, France","Team Immunity and Cancer, Centre De Recherche En Canc\u00e9rologie De Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Marseille, France","institution_ids":["https://openalex.org/I21491767","https://openalex.org/I4210150365"]},{"raw_affiliation_string":"Team Immunity and Cancer, Centre De Recherche En Canc\u00e9rologie De Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210144608","https://openalex.org/I4210150365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070064378","display_name":"Ida De Luca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ida De Luca","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112592074","display_name":"Chiara Brando","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Brando","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044527837","display_name":"Mimma Rizzo","orcid":"https://orcid.org/0000-0001-7743-741X","observed_orcids":["https://orcid.org/0000-0001-7743-741X"]},"institutions":[{"id":"https://openalex.org/I4210091499","display_name":"Istituti Clinici Scientifici Maugeri","ror":"https://ror.org/00mc77d93","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091499","https://openalex.org/I4210105320","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mimma Rizzo","raw_affiliation_strings":["I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy","Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7743-741X","affiliations":[{"raw_affiliation_string":"I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy","institution_ids":["https://openalex.org/I4210091499"]},{"raw_affiliation_string":"Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy","institution_ids":["https://openalex.org/I4210091499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053526286","display_name":"Carlo G. M. Messina","orcid":"https://orcid.org/0000-0002-7934-1419","observed_orcids":["https://orcid.org/0000-0002-7934-1419"]},"institutions":[{"id":"https://openalex.org/I4210088115","display_name":"Ospedale Santa Chiara","ror":"https://ror.org/007x5wz81","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210088115"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carlo Messina","raw_affiliation_strings":["Santa Chiara Hospital, Trento, Italy","Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Santa Chiara Hospital, Trento, Italy","institution_ids":["https://openalex.org/I4210088115"]},{"raw_affiliation_string":"Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy","institution_ids":["https://openalex.org/I4210088115"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063122523","display_name":"Mattia Rediti","orcid":"https://orcid.org/0000-0002-6713-2599","observed_orcids":["https://orcid.org/0000-0002-6713-2599"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Mattia Rediti","raw_affiliation_strings":["Jules Bordet Institut, L\u2019Universit\u00e9 Libre De Brussels, Belgium","Breast Cancer Translational Research Laboratory, Jules Bordet Institut, L\u2019Universit\u00e9 Libre De Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jules Bordet Institut, L\u2019Universit\u00e9 Libre De Brussels, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]},{"raw_affiliation_string":"Breast Cancer Translational Research Laboratory, Jules Bordet Institut, L\u2019Universit\u00e9 Libre De Brussels, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100635707","display_name":"Antonio Dello Russo","orcid":"https://orcid.org/0000-0002-4370-2008","observed_orcids":["https://orcid.org/0000-0002-4370-2008"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Antonio Russo","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033609878","display_name":"Viviana Bazan","orcid":"https://orcid.org/0000-0003-0939-255X","observed_orcids":["https://orcid.org/0000-0003-0939-255X"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Viviana Bazan","raw_affiliation_strings":["University of Palermo, Palermo, Italy","Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.n.d.), Section of Medical Oncology, University of Palermo, Palermo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]},{"raw_affiliation_string":"Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.n.d.), Section of Medical Oncology, University of Palermo, Palermo, Italy","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066948009","display_name":"Juan Iovanna","orcid":"https://orcid.org/0000-0003-1822-2237","observed_orcids":["https://orcid.org/0000-0003-1822-2237"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210144608","display_name":"Centre de Recherche en Canc\u00e9rologie de Marseille","ror":"https://ror.org/0494jpz02","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210096427","https://openalex.org/I4210144608","https://openalex.org/I4210150365"]},{"id":"https://openalex.org/I4210150365","display_name":"Institut Paoli-Calmettes","ror":"https://ror.org/04s3t1g37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210150365"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Juan Lucio Iovanna","raw_affiliation_strings":["Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Parc Scientifique Et Technologique De Luminy, Marseille, France","Team Pancreatic Cancer, Centre De Recherche En Canc\u00e9rologie De Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Parc Scientifique Et Technologique De Luminy, Marseille, France"],"raw_orcid":"https://orcid.org/0000-0003-1822-2237","affiliations":[{"raw_affiliation_string":"Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Parc Scientifique Et Technologique De Luminy, Marseille, France","institution_ids":["https://openalex.org/I21491767","https://openalex.org/I4210150365"]},{"raw_affiliation_string":"Team Pancreatic Cancer, Centre De Recherche En Canc\u00e9rologie De Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Universit\u00e9 and Institut Paoli-Calmettes, Parc Scientifique Et Technologique De Luminy, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I21491767","https://openalex.org/I4210144608","https://openalex.org/I4210150365"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5100635707"],"corresponding_institution_ids":["https://openalex.org/I900890020"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":5.5101,"has_fulltext":true,"cited_by_count":93,"citation_normalized_percentile":{"value":0.97207668,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"9","issue":"1","first_page":"1832348","last_page":"1832348"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-clear-cell-renal-cell-carcinoma","display_name":"metastatic clear cell renal cell carcinoma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6370000243186951},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8180000185966492},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/btn3a1","display_name":"BTN3A1","score":0.9860000014305115},{"id":"https://openalex.org/keywords/btn2a1","display_name":"BTN2A1","score":0.9449999928474426},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.7670000195503235},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8629999756813049},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9800000190734863},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9364564418792725},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.85610032081604},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.8142002820968628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6131370067596436},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.611589252948761},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6035809516906738},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5991805791854858},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4837234318256378},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4803506135940552},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.47768646478652954},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4701179265975952},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.46018892526626587},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4592049717903137},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.44376495480537415},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.41564059257507324},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4072558283805847},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3866519331932068},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22265687584877014},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1812562644481659},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.17373210191726685},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07094177603721619},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071797","descriptor_name":"Butyrophilins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1080/2162402x.2020.1832348","doi":"https://doi.org/10.1080/2162402x.2020.1832348","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2020.1832348","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1832348?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmid:33178494","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33178494","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7595592","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7595592/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmh:oai:HAL:hal-03152735v1","doi":null,"is_oa":false,"landing_page_url":"https://amu.hal.science/hal-03152735","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, 2020, 9 (1), pp.1832348. &#x27E8;10.1080/2162402X.2020.1832348&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/316725","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/316725","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Oncoimmunology, 9 (1","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:dfcd947f0514466dbd4babe39bc9b655","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dfcd947f0514466dbd4babe39bc9b655","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, Vol 9, Iss 1 (2020)","raw_type":"article"},{"id":"pmh:oai:iris.unipa.it:10447/439330","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10447/439330","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:ricerca.uniba.it:11586/326456","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11586/326456","pdf_url":null,"source":{"id":"https://openalex.org/S4377196296","display_name":"CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5561750","host_organization_name":"University of Bari Aldo Moro","host_organization_lineage":["https://openalex.org/I5561750"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2020.1832348","doi":"https://doi.org/10.1080/2162402x.2020.1832348","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2020.1832348","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1832348?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3096790401.pdf","grobid_xml":"https://content.openalex.org/works/W3096790401.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1580205301","https://openalex.org/W1972885538","https://openalex.org/W2066671159","https://openalex.org/W2069399470","https://openalex.org/W2073125824","https://openalex.org/W2086842268","https://openalex.org/W2145758395","https://openalex.org/W2148706732","https://openalex.org/W2222086386","https://openalex.org/W2260197997","https://openalex.org/W2267145540","https://openalex.org/W2314057593","https://openalex.org/W2324094374","https://openalex.org/W2343744278","https://openalex.org/W2409503508","https://openalex.org/W2534845525","https://openalex.org/W2559826815","https://openalex.org/W2615907969","https://openalex.org/W2735460229","https://openalex.org/W2752072744","https://openalex.org/W2766990963","https://openalex.org/W2780379277","https://openalex.org/W2791673886","https://openalex.org/W2792656817","https://openalex.org/W2792937256","https://openalex.org/W2884170377","https://openalex.org/W2890014497","https://openalex.org/W2893024156","https://openalex.org/W2901441980","https://openalex.org/W2902620090","https://openalex.org/W2903582814","https://openalex.org/W2911115971","https://openalex.org/W2912986834","https://openalex.org/W2913745075","https://openalex.org/W2936018467","https://openalex.org/W2944937890","https://openalex.org/W2947589787","https://openalex.org/W2951424976","https://openalex.org/W2966740586","https://openalex.org/W2967350775","https://openalex.org/W2969782175","https://openalex.org/W2990157180","https://openalex.org/W3007964415","https://openalex.org/W3018979351"],"related_works":["https://openalex.org/W3152513665","https://openalex.org/W3088629847","https://openalex.org/W4295681444","https://openalex.org/W4360606622","https://openalex.org/W3008811415","https://openalex.org/W3101944860","https://openalex.org/W2798065888","https://openalex.org/W4317941632","https://openalex.org/W4324136283","https://openalex.org/W3031088940"],"abstract_inverted_index":{"Despite":[0],"a":[1,36,72,121,176,192],"proportion":[2],"of":[3,44,75,107,169,179,185,196,214,235],"renal":[4,79],"cancer":[5,250],"patients":[6,82],"can":[7,219],"experiment":[8],"marked":[9],"and":[10,22,53,114,154,166,217,239,252],"durable":[11],"responses":[12],"to":[13,39,58,62,126,222,244],"immune-checkpoint":[14,63],"inhibitors,":[15],"the":[16,24,45,60,68,85,204,211,233,246],"treatment":[17,128],"efficacy":[18],"is":[19],"widely":[20],"variable":[21],"identifying":[23],"patient":[25],"who":[26],"will":[27],"benefit":[28],"from":[29,226],"immunotherapy":[30],"remains":[31],"an":[32],"issue.":[33],"We":[34,66],"performed":[35],"prospective":[37],"study":[38,208],"investigate":[40],"if":[41],"soluble":[42],"forms":[43],"immune-checkpoints":[46],"PD-1":[47],"(sPD-1),":[48],"PD-L1":[49],"(sPD-L1),":[50],"pan-BTN3As,":[51],"BTN3A1,":[52],"BTN2A1,":[54],"could":[55],"be":[56],"candidate":[57],"predict":[59,220],"response":[61,163,168,221],"blockade":[64],"therapy.":[65],"evaluated":[67],"plasma":[69,186,212],"levels":[70,106,131,156,213],"in":[71,175,203],"learning":[73],"cohort":[74,178],"metastatic":[76],"clear":[77],"cell":[78],"carcinoma":[80],"(mccRCC)":[81],"treated":[83],"with":[84,120,160,232],"anti-PD-1":[86],"agent":[87],"nivolumab":[88,127,190],"by":[89,164],"ad":[90],"hoc":[91],"developed":[92],"ELISA\u2019s.":[93],"Using":[94],"specific":[95],"cut-offs":[96],"determined":[97],"through":[98],"ROC":[99],"curves,":[100],"we":[101],"showed":[102,191],"that":[103,210,242],"high":[104],"baseline":[105],"sPD-1":[108,153,197],"(>2.11":[109],"ng/ml),":[110,113],"sPD-L1":[111],"(>0.66":[112],"sBTN3A1":[115,155,218],"(>6.84":[116],"ng/ml)":[117],"were":[118,157,173],"associated":[119,159],"longer":[122],"progression-free":[123],"survival":[124],"(PFS)":[125],"[median":[129],"PFS,":[130],"above":[132],"thresholds:":[133],"sPD-1,":[134,215],"20.7":[135],"months":[136,142,148],"(p":[137,143,149],"<":[138,144],".0001);":[139,145],"sPD-L1,":[140,216],"19":[141],"sBTN3A1,":[146],"17.5":[147],"=":[150],".002)].":[151],"High":[152],"also":[158],"best":[161],"overall":[162],"RECIST":[165],"objective":[167],">20%.":[170],"The":[171,183],"results":[172],"confirmed":[174],"validation":[177],"20":[180],"mccRCC":[181],"patients.":[182,206],"analysis":[184],"dynamic":[187,247],"changes":[188,248],"after":[189,198],"statistically":[193],"significant":[194],"decrease":[195],"2":[199],"cycles":[200],"(Day":[201],"28)":[202],"long-responder":[205],"Our":[207],"revealed":[209],"nivolumab,":[223],"discriminating":[224],"responders":[225],"non-responders":[227],"already":[228],"at":[229],"therapy":[230],"baseline,":[231],"advantages":[234],"non-invasive":[236],"sample":[237],"collection":[238],"real-time":[240],"monitoring":[241],"allow":[243],"evaluate":[245],"during":[249],"evolution":[251],"treatment.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3096790401","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-11-09T00:00:00"}
